As members of Congress return to their districts for Easter recess, AARP is kicking off a new phase of its Fair Drug Prices Now campaign and pushing lawmakers to advance the prescription drug pricing provisions, including allowing Medicare to negotiate, already passed by the House, as a top priority when they return.

There is strong scientific evidence that behavior changes and lifestyle habits can have a positive impact on brain health – yet many adults struggle to implement such changes. In a new report released today, “How to Sustain Brain Healthy Behaviors: Applying Lessons of Public Health and Science to Drive Change,” the Global Council on Brain Health (GCBH) outlines how individuals, communities and policymakers can all take steps to support brain health.

AARP CEO Jo Ann Jenkins issued the following statement on the second anniversary of the COVID-19 pandemic

Today AARP launched new television and digital advertising featuring Larry Zarzecki, a retired law enforcement officer with Parkinson’s disease who was forced to sell his home in order to afford his medications. Zarzecki first shared his story in an AARP ad three years ago, but Congress’ failure to act means he has had no relief from the high cost of his treatments. As he says in the new ad, “I shouldn’t have to decide between my home or my medicine because Congress refuses to act. I’m tired of waiting for Congress.”

AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to President Biden’s remarks today about the need to lower prescription drug prices